Drug class
Depigmenting phenolic agent; monobenzyl ether of hydroquinone
Mechanism of action
Causes irreversible depigmentation of melanocytes in treated skin, likely through melanocyte toxicity and interference with melanin synthesis. The mechanism is not fully characterised and the effect is not selective to lesional skin.
General use cases
- Historically used to depigment remaining normally pigmented skin in patients with extensive vitiligo when depigmentation of the remaining skin is desired; use is specialist-directed and product authorisation varies by jurisdiction
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
